Read the original post:
Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc.

Read the rest here:
scPharmaceuticals to Participate in Two Upcoming Investor Conferences

Read the original here:
Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab

Continued here:
Levitee Labs Publishes First Revenue Figures for August 2021

Read more here:
TFF Pharmaceuticals to Hold Third Quarter 2021 Financial and Business Results Conference Call on November 15, 2021

Continue reading here:
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.

Read the original here:
CRISPR Therapeutics to Host Virtual Event Highlighting CTX110™ Clinical Data

Read the original:
Shockwave Medical to Report Third Quarter 2021 Financial Results on November 8, 2021

See original here:
Adagene to Present at Upcoming Investor Conferences

Continued here:
Neuronetics Announces Commercial Agreement with Success TMS

Read more from the original source:
Osmotica Pharmaceuticals plc to Present at Jefferies Virtual Healthcare Conference 2021

See the article here:
Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired...

Continue reading here:
Shockwave Medical to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021

Originally posted here:
Spero Therapeutics Provides Update on SPR720 Phase 2a Clinical Trial

Continued here:
Neoleukin Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days

Original post:
Sorrento to Present Data Demonstrating STI-2020 Preserves Binding Against UK B.1.1.7 SARS-CoV-2 Mutated Spike Protein

Read more:
Histogen Reports FDA Clinical Hold for Planned Phase 1/2 Trial of HST-003 for Knee Cartilage Regeneration

Go here to see the original:
Genocea to Participate in the B. Riley Securities’ Virtual Oncology Investor Conference

Read the original post:
Eledon Pharmaceuticals to Participate in the Virtual Noble Capital Markets' Seventeenth Annual Investor / Equity Conference

See more here:
Mindset Pharma Recaps 2021 Milestones and Highlights